We investigated the outcome of uvulopalatopharyngoplasty (UPPP) combined with radiofrequency thermotherapy of the tongue base (RFTB) in patients with obstructive sleep apnea syndrome (OSAS) with both palatal and retroglossal obstruction, and we compared these results with the results of single level surgery (UPPP). A retrospective cohort study was performed in patients with mild to severe OSAS who underwent UPPP with or without RFTB. Seventy-five patients with both palatal and retroglossal obstruction underwent UPPP, 38 patients without RFTB (group 1) and 37 patients with RFTB (group 2). The outcome of the surgery was measured by both objective success (defined as a reduction of AHI >50% and AHI below 20) and subjective improvement. In group 1 the overall success rate was 42%, and in group 2 49%. Other polysomnographic values (AI, DI, mean SaO2) improved after surgery (not significant). No serious adverse events occurred. Surgical treatment of combined palatal and retroglossal obstruction remains a challenge. Adding RFTB to UPPP results in a mild improvement compared to UPPP alone. Although the addition of RFTB to UPPP seems to result in only a limited improvement, there is no major downside to it. RFTB is well tolerated and safe.

Choice of the most appropriate ear for CI in postlingually hearing-impaired adults is becoming more relevant as more patients are considered eligible for intervention. The aim of this study is to review factors that influence this choice and to formulate a flowchart. An extensive Medline search was performed. Factors can be divided into surgical, audiological, and patient factors. Surgical factors are anatomic variation and otological medical history. Both are divided in absolute and relative contraindications. Duration of deafness and residual hearing are combined in the audiological factor. Likeliness of improvement of speech perception after CI at different durations of deafness is estimated. This is followed by comparison of between-ear differences in duration of deafness. If there is a large difference, above the presented 5% interval, the ear with the shortest duration is preferred. This review and its flowchart are an aid for decision making in the choice of ear for CI. Being as representative of current knowledge as possible, future refinements may occur as new insights are gained.

The third sentence of the second paragraph in "Discussion" should read:Adding RFTB to UPPP gave an increase in objective success rate of 17.2%, from 37.9 to 55.1% for Friedman stage II patients and an increase of 24.9%, from 8.1 to 33.0% for stage III patients.The online version of the original article can be found under